Latest filing published 05 Jun 2020 for Sangamo Therapeutics, INC.
Insider track record
No signal scores available.
Stephane Boissel: trading record in brief
Stephane Boissel appears in our data through filings on Sangamo Therapeutics, Inc shares, published by SEC (Form 4). The record holds 7 filings, for trades running from 25 February 2019 to 4 June 2020.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 5 June 2020, reports a transaction of €148k in Sangamo Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Stephane Boissel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 14,907 sharesCommon StockSEC:0001209191-20-034882:0
- 14,907 shares@ US$11.23Common StockSEC:0001209191-20-034882:1
- 2,384 shares@ US$6.80Common StockSEC:0001209191-20-013229:0
- 55,000 shares0Common StockSEC:0001209191-20-013229:1
- 11,137 sharesCommon StockSEC:0001209191-19-045963:0
- 11,137 shares@ US$11.23Common StockSEC:0001209191-19-045963:1
- 17,500 shares0Common StockSEC:0001209191-19-014302:0
7 of 7 declarations
